News » Archives » February 2015

Father Theodore Hesburgh of Notre Dame dies at age 97

Author: Dennis Brown

Rev. Theodore M. Hesburgh, C.S.C., saying Mass

Rev. Theodore M. Hesburgh, C.S.C., president of the University of Notre Dame from 1952 to 1987, a priest of the Congregation of Holy Cross and one of the nation’s most influential figures in higher education, the Catholic Church and national and international affairs, died at 11:30 p.m. Thursday (Feb. 26) at Holy Cross House adjacent to the University. He was 97.

“We mourn today a great man and faithful priest who transformed the University of Notre Dame and touched the lives of many,” said Rev. John I. Jenkins, C.S.C., Notre Dame’s president. “With his leadership, charisma and vision, he turned a relatively small Catholic college known for football into one of the nation’s great institutions for higher learning."

Read More

Investigating aggressive, lethal breast tumors of Kenyan cancer patients

Author: Stephanie Healey

Maggie Kerper

Maggie Kerper came to college interested in science, but really developed a passion for the field after taking her first college-level science classes. After transferring to Notre Dame as a sophomore, she decided to find ways to explore science outside of the classroom.   

Kerper began working with Laurie Littlepage, Campbell Assistant Professor of Cancer Research in the Department of Chemistry and Biochemistry, during the spring of her sophomore year. “I went to an extra credit talk given by Prof. Littlepage and was so impressed and interested in her work. I had no idea cancer research opportunities like this existed on campus,” she explains. “I immediately felt drawn to get involved. I can’t think of any other field that I would feel the sort of gratification and drive to work harder than the cancer field.”

Read More

Chemistry in motion

Author: Michael Rodio

Amanda Hummon

To say that Amanda Hummon is busy these days—even by Notre Dame standards of busy—would be an understatement. She insists otherwise, of course. But consider this: In addition to teaching classes to Notre Dame undergraduates, Hummon is guiding no less than four major research projects this academic year on varying aspects of cancer research.

Read More

Scientia hosts first Talk Science: Innovation Series of the semester

Author: Shadia Ajam

chang_hsueh_chia250

The students from Scientia, the undergraduate journal of scientific research, host a monthly seminar series called Talk Science that highlights the work of undergraduate and faculty researchers at the University. This semester, Talk Science will focus on research that can be applied in innovative ways. This month’s presenters were junior biological sciences major Vincent Riccelli and Hsueh-Chia Chang, professor of chemical and biomolecular engineering. 

Read More

Targeting ovarian cancer stem cells

Author: John Fineran

Karen Cowden Dahl

At the age of 15, Karen Cowden Dahl began to seriously consider what she wanted to do with her life. Her decision would be an easy one. You might say, her career choice was a product of her environment, similar to the disease she researches and fights at the Mike and Josie Harper Cancer Research Institute on the University of Notre Dame campus.

“My mother was a nurse, my father was a pharmacist,” she reflected recently. “So I had the medical background. For a year or so I thought about becoming a medical doctor. But then I decided I wanted to find out what causes diseases because before you cure you have to know what the cause is.”

Read More

New antibiotic holds promise against antibiotic-resistant infections

Author: Gene Stowe

Mayland Chang and Shahriar Mobashery

Estimates of deaths from methicillin-resistant Staphylococcus aureus (MRSA) in the United States range upwards of 19,000 annually. Around 1960, when Staphylococcus aureus developed resistance to first-generation penicillin, methicillin and other second-generation beta-lactam antibiotics were adopted to fight the illness. The modern variants of the bacterium have developed resistance to the four drugs now used to treat it.

A team of researchers led by Shahriar Mobashery and Mayland Chang at the University of Notre Dame has discovered a promising new antibiotic, a vital weapon against disease as pathogens evolve to develop resistance to long-used drugs.

Read More

Notre Dame among top producers of Fulbright students

Author: Michael O. Garvey

Fulbright U.S. Scholar Program

Ten University of Notre Dame students have been awarded Fulbright grants in the 2014-15 program, placing the University among the top-producing universities in the nation.

The U.S. government’s flagship international educational exchange program, Fulbright recently announced the complete list of colleges and universities that produced the most 2014-15 U.S. Fulbright students. The success of the top-producing institutions is highlighted in Thursday’s edition (Feb. 12) of The Chronicle of Higher Education.

Read More

Crunching the numbers: Beating cancer with math

Author: Samria O'Brien

Stephanie Wachs

It is hard for cancer research to advance without using quantitative methods to learn more about certain diseases.  Statistics are especially important not only in better understanding cancer but the treatments that are often offered. This is an area in which Stephanie Wachs, a current senior at Notre Dame, has a lot to offer. 

Read More

Flanagan emphasizes the importance of taking charge of your own health at Pink Zone Brunch

Author: Julia Murray and Stephanie Healey

Lynn Flanagan

Alumna Lynn Larkin Flanagan ’75, a member of the first group of women accepted to the University of Notre Dame and a breast cancer survivor, spoke about her experience with cancer at the fifth annual Pink Zone Brunch on Feb. 1 (Sun.). Each year the brunch is hosted by the College of Science and the Notre Dame women’s basketball team to honor breast cancer researchers, clinicians, survivors, and their supporters.

Read More